# Prospective Multicenter Study Evaluating Myval TAVR Safety and Effectiveness in High-risk Severe AR

> **NCT07751965** · NA · NOT_YET_RECRUITING · sponsor: **Ceric Sàrl** · enrollment: 164 (estimated)

## Conditions studied

- Aortic Regurgitation
- Aortic Disease
- Calcified Aortic Valve

## Interventions

- **DEVICE:** Myval THV series

## Key facts

- **NCT ID:** NCT07751965
- **Lead sponsor:** Ceric Sàrl
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-30
- **Primary completion:** 2027-12-30
- **Final completion:** 2032-03-30
- **Target enrollment:** 164 (ESTIMATED)
- **Last updated:** 2026-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07751965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07751965, "Prospective Multicenter Study Evaluating Myval TAVR Safety and Effectiveness in High-risk Severe AR". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07751965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*